Serotonin Selective Reuptake Inhibitors

The serotonin selective reuptake inhibitors (SSRIs) are considered by most clinicians to be the first choice for the treatment of depression because of their relatively benign side effect profile. Their mechanism of action is similar to that of the TCAs but with a highly specific 5-HT reuptake inhibition action preventing the degradation of this neurotransmitter by MAO. There are currently five SSRI compounds marketed in the United States: fluoxetine, sertraline, paroxetine, fluvoxamine, and citalopram. Since these SSRIs differ in their potency, selectivity, and side effects profile, patients intolerant to one compound of this group can often be treated with another. SSRIs have a significant cytochrome P450 inhibition action that can result in a toxic level of coadministered drugs, such as alcohol, antihistamines, and anticholinergics.

All About Alzheimers

All About Alzheimers

The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.

Get My Free Ebook

Post a comment